WST West Pharmaceutical Services Inc

$248.00

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Website: https://www.westpharma.com

Sector
MANUFACTURING
Industry
FABRICATED RUBBER PRODUCTS, NEC
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
105770
Address
530 HERMAN O. WEST DRIVE, EXTON, PA, US
Valuation
Market Cap
$14.60B
P/E Ratio
30.22
PEG Ratio
3.38
Price to Book
5.44
Performance
EPS
$6.68
Dividend Yield
0.42%
Profit Margin
17.00%
ROE
17.70%
Technicals
50D MA
$229.60
200D MA
$293.32
52W High
$393.65
52W Low
$187.43
Fundamentals
Shares Outstanding
72M
Target Price
$284.51
Beta
1.22

WST EPS Estimates vs Actual

● Estimated
● Actual

WST News & Sentiment

Aug 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
Aug 21, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.
Aug 21, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones, and a balanced portfolio despite tariff headwinds.
Aug 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring
MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.
Aug 19, 2025 • Zacks Commentary NEUTRAL
NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment
NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.
Aug 19, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds
COO leans on innovation and diversification to fuel growth, but fertility softness, tariffs and inventory headwinds weigh on near-term outlook.
Sentiment Snapshot

Average Sentiment Score:

0.057
50 articles with scored sentiment

Overall Sentiment:

Neutral

WST Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
0.19 Surprise
  • Reported EPS: $1.45
  • Estimate: $1.26
  • Whisper: —
  • Surprise %: 15.3%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $1.82
  • Estimate: $1.71
  • Whisper: —
  • Surprise %: 6.4%
Oct 24, 2024
Sep 30, 2024 (Pre market)
0.35 Surprise
  • Reported EPS: $1.85
  • Estimate: $1.50
  • Whisper: —
  • Surprise %: 23.3%
Jul 25, 2024
Jun 30, 2024 (Pre market)
-0.22 Surprise
  • Reported EPS: $1.52
  • Estimate: $1.74
  • Whisper: —
  • Surprise %: -12.6%
Apr 25, 2024
Mar 31, 2024 (Pre market)
0.3 Surprise
  • Reported EPS: $1.56
  • Estimate: $1.26
  • Whisper: —
  • Surprise %: 23.8%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $1.83
  • Estimate: $1.78
  • Whisper: —
  • Surprise %: 2.8%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $2.16
  • Estimate: $1.86
  • Whisper: —
  • Surprise %: 16.1%
Jul 27, 2023
Jun 30, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $2.11
  • Estimate: $1.93
  • Whisper: —
  • Surprise %: 9.3%
Apr 27, 2023
Mar 31, 2023 (Pre market)
0.31 Surprise
  • Reported EPS: $1.98
  • Estimate: $1.67
  • Whisper: —
  • Surprise %: 18.6%

Financials